Wednesday, December 2, 2020
Elder Caregiving Webinar with Richard Lui
"3rd Act Journey" YouTube Channel
"A society grows great when ELDERS plants trees whose shade they will never enjoy."
This is my modification of an ancient Greek saying that serves as a slogan for my new YouTube channel: "3rd Act Journey." I think the tree motif works well with connotating wisdom achieved through a long life.
Nebraska’s state nickname before the “Cornhusker State” was the “Tree Planter’s State.” Settlers coming to the prairie were ambitious in planting trees because they had a vision for a better life. It is for this reason that this state is the home of Arbor Day.
The seniors in our society have the responsibility to use their wisdom and perspective to begin initiating changes for which future generations will benefit, something very similar to tree planting.
For this reason, my organization Elder Lives and its YouTube channel 3rd Act Journey use images of trees to represent the needed long-term solutions.
The next step in my journey is to develop my online media and engage in speaking opportunities, as well as write a book to share my vision, engaging and inspiring others to have a purpose of creating a better future.
Monday, November 23, 2020
"The Good Ancestor: A Radical Prescription for Long-Term Thinking" by Roman Krznaric
After a quick investigation, I realized that this was the perfect read for developing the direction of my Elder Lives blog and organization.
“A society grows great when ELDERS plant trees whose shade they will never enjoy,” is my version of an supposedly ancient Greek aphorism, and conveys my feeling about my current mission.
Nebraska’s state nickname before the “Cornhusker State” was the “Tree Planter’s State.” Settlers coming to the prairie were ambitious in planting trees because they had a vision for a better life. It is for this reason that this state is the home of Arbor Day.
The seniors in our society have the responsibility to use their wisdom and perspective to begin initiating changes for which future generations will benefit, something very similar to tree planting.
For this reason, my organization Elder Lives and its YouTube channel 3rd Act Journey use images of trees to represent the needed long-term solutions.
The next step in my journey is to develop my online media and engage in speaking opportunities to share my vision, engaging and inspiring others to have a purpose of creating a better future.
Here's the blurb from YouTube: "Philosopher Roman Krznaric discusses his most recent book "The Good Ancestor: A Radical Prescription for Long-Term Thinking". Krznaric explores six ways we can expand our time horizons to confront the long-term challenges of our age— from the threats of climate change to the lack of planning for a global pandemic. Do we have what it takes to become the good ancestors that future generations deserve?"
Friday, November 20, 2020
"How Covid-19 Will Change Aging and Retirement" WSJ Report
"How Covid-19 Will Change Aging and Retirement: Among other things, expect more aging in place and a wave of innovation," is the title of the supplement in the November 16th edition of the WSJ.
![]() |
| Ai-jen Poo |
Technology will play a key role for the elderly
Wednesday, November 18, 2020
Music Training for Seniors
I tell people, yes, I did take piano lessons for a short while. Then I add it was over 54 years ago.
What got me thinking to make it a better effort this time was my interest in music theory, and the questions that have always bothered me, such as why is the 12 semi-tone scale called an octave, i.e., why the 8 notes selected as the consecutive white keys on a piano for the C major scale. I think I found the best explanation on YouTube and will include it in a later post. (Interesting to note [pun intended] that historically other modes besides the major and minor scales were used: The Medieval Church Modes, Dorian Scales & Mixolydian Scale.)
I began looking into YouTube posts from which I picked up some finger exercises, but more importantly found some very useful resources:
Leonard Bernstein’s Young People's Concert: "What is a Mode?" with the New York Philharmonic
Rick Beato is a music professor and Rock music studio engineer who provides music theory lessons, but also explores classical music. In one video he expresses his admiration for the 79-year-old pianist Martha Argerich (see next).
(from Wikipedia) Martha Argerich (born June 5, 1941) is an Argentine concert pianist. Her aversion to the press and publicity has resulted in her remaining out of the limelight for most of her career. She has given relatively few interviews. As a result, she may not be as well known as other pianists of similar calibre. Nevertheless, she is widely recognized as one of the greatest modern-day pianists.
Lisa Witt's Pianote provides an online piano course, which I discovered on YouTube, and I'm currently a member. I'll be evaluating my experience in upcoming blog posts.
I have to thank Dr. Marie Rubis Bauer, Archdiocesan Director of Music and Cathedral Organist at Saint Cecilia Cathedral in Omaha, who sat with me at a grand piano to give me a few pointers on how to restart my music interests.
Anyway, so to begin again I purchase a used 66-key, Yamaha electronic keyboard from the Guitar Center in Danvers, MA. I found this item with an online search and had it sent to me here in Omaha. Kudos to the people who were great in packing and shipping this keyboard:
For music books, I purchased "For the Older Beginner: Accelerated Piano Adventures" by Nancy and Randall Faber.
Another instrument to consider, which I picked up, is the harmonica. It's a good breathing exerciser, and might be beneficial for those with COPD or the elderly in general.
"BAM-la-nih-VAH-mab" or Bamlanivimab, FDA-approved monoclonal Antibody for Covid-19
I see physicians online have taken to call this recently-approved monoclonal antibody treatment the "B-word." Just say BAM-la-nih-VAH-mab.
From the November 9th FDA news release: "Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. Bamlanivimab is authorized for patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88 pounds), and who are at high risk for progressing to severe COVID-19 and/or hospitalization. This includes those who are 65 years of age or older, or who have certain chronic medical conditions."
As Dr. Lawler mentioned in the interview I covered in another blog post, this is an much needed out-patient treatment.
Important to note that the safety and effectiveness evaluation is still ongoing. But so far, "bamlanivimab was shown in clinical trials to reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression within 28 days after treatment when compared to placebo."
Bamlanivimab has not shown a benefit to patients hospitalized due to COVID-19 or require oxygen therapy, therefore is not authorized for these patients.
The FDA news release goes on to warn: "Monoclonal antibodies, such as bamlanivimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation."
What is a monoclonal antibody?
"Monoclonal" means that all these antibodies are identical. In the body, an immune response results in the production of a wide variety of antibodies with different binding strengths. You want your treatment antibody to have high specificity or strong affinity for the invading virus.A very interesting process is used to manufacture these antibodies. The image at the right starts with mouse immunological spleen cells put in contact with the virus or parts of it believed to elicit an immune response.
These cells are then fused with cancer cells, because the myeloma cells used are virtually immortal, growing prolifically in culture through many generations.
This hybridoma is allowed to grow in culture after which cells producing the specific antibody desired are selected. These cells produce the monoclonal antibodies which are harvested and used for treatment.
Tuesday, November 17, 2020
Dr. James Lawler of UNMC on Covid-19 Vaccine, Treatment and Testing
For current treatment options, Dr. Lawler said that this involves basic supportive care and high flow oxygen or mechanical ventilation when needed. He also said a new, monoclonal antibody product with good efficacy in the out-patient setting will be rolled out across the state. He emphasized that out-patient treatment like this therapy is preferred.
When asked about false negatives in testing, he said that the virus has an incubation period of up to 14 days after exposure. A person getting testing in the early part of the infection might test negative, so the advice is to test after 3 to 4 days from exposure, and then tested again later.
UPDATE: I did get confirmation from UNMC that the monoclonal antibody Dr. Lawler is referring to is bamlanivimab, which has just been approved for emergency use authorization (EUA) by the FDA.
#AGS21 - American Geriatrics Society 2021 Virtual Annual Meeting
From the American Geriatrics Society Web site : "Founded in 1942, the American Geriatrics Society (AGS) is a nationwide, not-for-profit...
-
"How Covid-19 Will Change Aging and Retirement: Among other things, expect more aging in place and a wave of innovation," is th...
-
From the American Geriatrics Society Web site : "Founded in 1942, the American Geriatrics Society (AGS) is a nationwide, not-for-profit...
-
The Oscars are here again, but chances are it will not have a strong viewership, partly because of the effects of the pandemic. However, I m...
















